Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COMBIGAN in Korean Patients with POAG and NTG
NCT02863705Phase 4Completed
- Sponsor
- Allergan
- Start
- Jul 2016
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of brimonidine tartrate + timolol maleate in primary open-angle glaucoma (POAG), normal tension glaucoma (NTG), sponsored by Allergan. Started Jul 2016; status: completed.
02
Drugs
brimonidine tartrate + timolol maleate
03
Conditions
primary open-angle glaucoma (POAG)normal tension glaucoma (NTG)
Beyond the preview
Go deeper on NCT02863705.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02863705.